Clinical trial
Umbilical Mesenchymal Stem Cells in the Treatment of Acute-on-Chronic Liver Failure：A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIb/III Seamless Adaptive Design Clinical Study
NCT06884904 is registered in ClinicalTrials.gov with National Engineering Center of Cell Products as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Mesenchymal Stem Cells in the Treatment of Acute-on-Chronic Liver Failure：A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIb/III Seamless Adaptive Design Clinical Study
- Lead sponsor
- National Engineering Center of Cell Products
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- April 15, 2025
- Completion date
- April 14, 2028
- Enrollment
- 96 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.